The paradox of immunosuppressants and COVID-19. | Eur Respir J;59(4)2022 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

The paradox of immunosuppressants and COVID-19.

Cheng, Guang-Shing; Evans, Scott E.

Cheng GS; Clinical Research Division, Fred Hutchinson Cancer Research Center and Division of Pulmonary Critical Care and Sleep Medicine, University of Washington School of Medicine, Seattle, WA, USA gcheng2@fredhutch.org.
Evans SE; Dept of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Eur Respir J ; 59(4)2022 04.

Article in English | MEDLINE | ID: covidwho-1526590

Subject(s)

COVID-19; Humans; Immunosuppressive Agents/therapeutic use; Prognosis; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.02828-2021

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.02828-2021